CPHI: China Pharma Holdings Inc. Company Short-Term Debt

Symbol and logo of brand China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings (CPHI) relies on stable demand for essential medicines, rendering its revenues insensitive to market volatility and seasonality. This historical price chart on GURU.Markets complements data regarding partnerships with Chinese clinics for the supply of mental health treatments, where the indicator stands at 0.00. However, a lack of innovation and stagnation in R&D limit the company's growth potential.

CPHI (chinapharmaholdings.com) Company Short-Term Debts history from 07/04/2022 to 11/01/2026

Comprehensive metric breakdowns and analytics for China Pharma Holdings Inc. (CPHI)

- current quotes and average value forecast:
Price Chart China Pharma|CPHI - Fair Value Consensus
- market capitalization information:
Market Value China Pharma Holdings, Inc.|CPHI - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share China Pharma Holdings|CPHI - Book Capitalization|Market Cap to Net Assets Ratio chinapharmaholdings.com|CPHI - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity China Pharma Holdings|CPHI - Long-Term Liabilities to Equity|Short-Term Debt to Equity China Pharma|CPHI - Company Total Debt Obligations|Debt to Book Value China Pharma Holdings, Inc.|CPHI - Long-Term Debt|Company Short-Term Debts China Pharma Holdings|Quick Ratio chinapharmaholdings.com
- net income and valuation multiples indicators:
CPHI - Final Profit
Fundamental company analysis:chinapharmaholdings.com - CPHI
Mass-produced product of China Pharma

Investors must balance current yields against liquidity risks to avoid unforeseen financial losses. By analyzing aggregate short-term liabilities, one can assess the ability of China Pharma Holdings (CPHI) to service urgent loans, which is critical for a mature business striving for cost optimization and maintaining the quality of its pharmaceutical pipeline under its development strategy through 2026.

Main competitors

ALKS - Company Short-Term Debt|Company Short-Term Loans and Borrowings AVDL (Avadel Pharmaceuticals PLC)|atai Life Sciences Corp (ATAI) - Company Short-Term Debt|Company Current Liabilities GH Research Group|MNMD (Mind Medicine) - Company Short-Term Debts|Company Short-Term Debts compasspathways.com|Company Current Liabilities LBRX (LB Pharmaceuticals)|DRUG (Bright Minds Bio) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Vanda Pharmaceuticals Inc VNDA|CYBN (Cybin Inc) - Current Liabilities|ANRO - Company Short-Term Debt|Short-Term Debt Volume nrxpharma.com NRXP|CING (cingulate.com) - Company Current Liabilities|Short-Term Debt Silo Pharma Inc. (SILO)|CMND (Clearmind Medicine Inc.) - Company Short-Term Debts|Company Current Liabilities Psyence Bio (PBM)|Company Short-Term Debts SPRC|SEEL (seelostherapeutics.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Virpax Pharmaceuticals, Inc. VRPX|Karuna Therapeutics Inc (KRTX) - Short-Term Debt